The Food and Drug Administration is letting Philip Morris International market its Zyn nicotine pouches as being safer than cigarettes.
The FDA said on June 30 that the pouches can now feature the statement, “Using Zyn instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.”
The authorization of the modified risk statement followed an extensive scientific review, regulators said.
That process concluded that Philip Morris subsidiary Swedish Match demonstrated the claim was scientifically accurate, that consumers understand the claim, and that marketing the products with the claim would benefit the population….